Androgen effects on the central nervous system in the postmenopausal woman

Seminars in Reproductive Endocrinology

Volumn 16, Issue 2, 1998, Pages 135-143

  Plouffe Jr , Leo ^a,b   Simon, James A ^c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c Women's Health Research Center   (United States)

Author keywords

Central nervous system; Libido; Menopause; Methyltestosterone; Testosterone

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; AROMATASE; ESTROGEN; ESTROGEN RECEPTOR; METHYLTESTOSTERONE; PROGESTERONE RECEPTOR; SEX HORMONE BINDING GLOBULIN; STEROID 5ALPHA REDUCTASE; TESTOSTERONE;

ANDROGEN METABOLISM; ANDROGEN THERAPY; CENTRAL NERVOUS SYSTEM FUNCTION; COGNITION; DRUG EFFECT; ESTROGEN THERAPY; EVIDENCE BASED MEDICINE; FEMALE; HORMONE ACTION; HUMAN; LIBIDO; MEMORY; MOOD; NONHUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW;

EID: 13044251827     PISSN: 07348630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1016264     Document Type: Review

References (97)

1. Greenblatt RB, Suran RR. Indications for hormonal pellets in the therapy of endocrine and gynecic disorders. Am J Obstet Gynecol 1949;57:294-301
2. Sands R, Studd J. Exogenous androgens in postmenopausal women. Am J Med 1995;98:76S-79S
3. Kerdelhue B, Renaud M. [Androgens and feminine behavior]. Contraception, Fertil Sex 1996;24:407-412
4. Casson PR, Carson SA. Androgen replacement therapy in women: Myths and realities. Int J Fertil Menop Studies 1996;41:412-422
5. Kaunitz AM. The role of androgens in menopausal hormonal replacement. Endo Metab Clin N Am 1997;26:391-397
6. Rosenberg MJ, King TD, Timmons MC. Estrogen-androgen for hormone replacement. A review. J Reprod Med 1997;42:394-404
7. Davis SR, Burger HG. Use of androgens in postmenopausal women. Curr Opin Obstet Gynecol 1997;9:177-180
8. Hormones, mood and cognitive functioning in postmenopausal women. Obstet Gynecol 1996;87:20S-26S
9. van Duijn CM. Menopause and the brain. J Psychosom Ob Gyn 18:121-5;1997 / Henderson VW. The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology 1997;48(Suppl. 7):S27-S35
10. van Duijn CM. Menopause and the brain. J Psychosom Ob Gyn 18:121-5;1997 / Henderson VW. The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology 1997;48(Suppl. 7):S27-S35
11. Pearlstein T, Rosen K, Stone AB. Mood disorders and menopause. Endocrinol Metab Clin North Am 1997;26:279-294
12. Bixo M, Backstrom T, Winblad B, Andersson A. Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J Ster Biochem Molec Biol 1995;55:297-303
13. Wood RI, Newman SW. Hormonal influence on neurons of the mating behavior pathway in male hamsters. In: Micevych PE, Hammer RP Jr, eds. Neurobiological Effects of Sex Steroid Hormones. New York: Cambridge University Press; 1995:3-39
14. Simerly RB. Distribution and regulation of steroid hormone receptor gene expression in the central nervous system. In: FJ Seil, ed. Advances in Neurology, vol. 59. New York: Raven Press; 1993:207-226
15. Luboshitzky R, Dharan M, Goldman D, Hiss Y, Herer P, Lavie P. Immunohistochemical localization of gonadotropin and gonadal steroid receptors in human pineal glands. J Clin Endocrinol Metab 1997;82:977-981
16. Kritzer MF. Selective colocalization of immunoreactivity for intracellular gonadal hormone receptors and tyrosine hydroxylase in the ventral tegmental area, substantia nigra, and retrorubral fields in the rat. J Comp Neurol 1997;10;379:247-260
17. Bakker J, Pool CW, Sonnemans M, van Leeuwen FW, Slob AK. Quantitative estimation of estrogen and androgen receptor-immunoreactive cells in the forebrain of neonatally estrogen-deprived male rats. Neuroscience 1997;77:911-919
18. Morrell JI, Wagner CK, Malik KF, Lisciotto CA. Estrogen receptor mRNA: Neuroanatomical distribution and regulation in three behaviorally relevant physiological models. In: Micevych PE, Hammer RP Jr, eds. Neurobiological Effects of Sex Steroid Hormones. New York': Cambridge University Press; 1995:57-84
19. Balthazart J. Steroid control and sexual differentiation of brain aromatase. J Steroid Biochem Mol Biol 1997;61:323-339
20. Mcewen BS, Alves SE, Bulloch K, Weland NG. Ovarian steroids and the brain-implications for cognition and aging. Neurology 1997;48(5 Suppl. 7):s8-s15
21. Desmond NL, Levy WB. Ovarian steroidal control of connectivity in the female hippocapmus - An overview of recent experimental findings and speculations on its functional consequences. Hippocampus 1997;7(2):239-245
22. Naftolin F, Leranth C, Horvath TL, Garcia-Segura LM. Potential neuronal mechanisms of estrogen action in synaptogenesis and synaptic plasticity. Cell Mol Neurobiol 1996;16:213-233
23. Hutchison JB, Beyer C, Hutchison RE, Wozniak A. Sex differences in the regulation of embryonic brain aromatase. J Steroid Biochem Mol Biol 1997;61:315-322
24. Beyer C, Green SJ, Hutchison JB. Androgens influence sexual differentiation of embryonic mouse hypothalamic aromatase neurons in vitro. Endocrinology 1994;135:1220-1226
25. Resko JA, Connolly PB, Roselli CE, Abdelgadir SE, Choate JV. Selective activation of androgen receptors in the subcortical brain of male cynomolgus macaques by physiological hormone levels and its relationship to androgen-dependent aromatase activity. J Clin Endocrinol Metab 1993;76:1588-1593
26. Celotti F, Melcangi RC, Negri-Cesi P, Poletti A. Testosterone metabolism in brain cells and membranes. J Steroid Biochem Mol Biol 1991;40:673-678
27. Celotti F, Melcangi RC, Martini L. The 5 alpha-reductase in the brain: Molecular aspects and relation to brain function. Frontiers Neuroendocrinol 1992;13:163-215
28. Poletti A, Negri-Cesi P, Melcangi RC, et al. Expression of androgen-activating enzymes in cultured cells of developing rat brain. J Neurochem 1997;68:1298-1303
29. Poletti A, Celotti F, Rumio C, Rabuffetti M, Martini L. Identification of type 1 5alpha-reductase in myelin membranes of male and female rat brain. Mol Cell Endocrinol 1997;129:181-190
30. Lauber ME, Lichtensteiger W. Ontogeny of 5 alpha-reductase (type 1) messenger ribonucleic acid expression in rat brain: Early presence in germinal zones. Endocrinology 1996;137:2718-2730
31. Fink G, Sumner BE, Rosie R, Grace O, Quinn JP. Estrogen control of central neurotransmission: Effect on mood, mental state, and memory. Cell Mol Neurobiol 1996;16:325-344
32. Lustig RH, Hua P, Smith LS, Wang C, Chang C. An in vitro model for the effects of androgen on neurons employing androgen receptor-transfected PC12 cells. Mol Cell Neurosci 1994;5:587-596
33. Martini L, Melcangi RC, Maggi R. Androgen and progesterone metabolism in the central and peripheral nervous system. J Steroid Biochem Mol Biol 1993;47:195-205
34. Lustig RH. Sex hormone modulation of neural development in vitro. Behavior 1994;28(4):383-395
35. Ritchie K, Leibovici D, Ledesert B, Touchon J. A typology of sub-clinical senescent cognitive disorder. Br J Psychiatry 1996;168:470-476
36. Jorm AF, Christensen H, Korten AE, et al. Do cognitive complaints either predict future cognitive decline or reflect past cognitive decline? A longitudinal study of an elderly community sample. Psychol Med 1997;27:91-98
37. Forstl H, Zerfass R, Geiger-Kabisch C, et al. Brain atrophy in normal ageing and Alzheimer's disease. Volumetric discrimination and clinical correlations. Br J Psychiatry 1995;167:739-746
38. Elmstahl S, Rosen I. Postural hypotension and EEG variables predict cognitive decline: Results from a 5-year follow-up of healthy elderly women. Dement Geriatr Cogn Disord 1997;8:180-187
39. Hill RD, Backman L. The relationship between the minimental state examination and cognitive functioning in normal elderly adults: A componential analysis. Age Ageing 1995;24:440-446
40. Schacter DL. Searching for memory: The brain, the mind and the past. New York: Basic Books; 1996
41. Fuster JM. Network memory. Trends Neurose 1997;20:451-459
42. Barberger-Gateau P, Fabrigoule C. Disability and cognitive impairment in the elderly. Disabil Rehabil 1997;19:175-193
43. Albert MS. The ageing brain: Normal and abnormal memory. Philos Trans R Soc Lond [Biol] 1997;352:1703-1709
44. Ritchie K, Touchon J, Ledesert B, Leibovici D, Gorce AM. Establishing the limits and characteristics of normal age-related cognitive decline. Rev Epidemiol Sante Publique 1997;45:373-381
45. Hanninen T, Koivisto K, Reinikainen KJ, et al. Prevalence of ageing-associated cognitive decline in an elderly population. Age Ageing 1996;25:201-205
46. Waite LM, Broe GA, Creasey H, et al. Neurological signs, aging, and the neurodegenerative syndromes. Arch Neurol 1996;53:498-502
47. Starr JM, Deary IJ, Inch S, Cross S, MacLennan WJ. Age-associated cognitive decline in healthy old people. Age Ageing 1997;26:295-300
48. Sherwin BB. Sex hormones and psychological functioning in postmenopausal women. Exp Gerontol 1994;29:423-430
49. Polo-Kantola P, Portin R, Koskinen T, et al. Climacteric symptoms do not impair cognitive performances in postmenopause. Maturitas 1997;27:13-23
50. Gouchie C, Kimura D. The relationship between testosterone levels and cognitive ability patterns. Psychoneuroendocrinology 1991;16:323-334
51. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988;13:345-357
52. Van Goozen SH, Cohen-Kettenis PT, Gooren LJ, Frijda NH, Van de Poll NE. Activating effects of androgens on cognitive performance: Causal evidence in a group of female-to-male transsexuals. Neuropsychologia 1994;32:1153-1157
53. Kay GG, Simon JA, Huh T, et al. Cognitive, Mood and Quality of Live: Double-Blind comparison of estrogen and estrogen-androgen therapy in surgically menopausal women. Eighth Annual Meeting of the North American Menopause Society, Boston, MA, September 1997
54. Moffat SD, Hampson E. A curvilinear relationship between testosterone and spatial cognition in humans: Possible influence of hand preference. Psychoneuroendocrinology 1996;21:323-337
55. Floter A, Nathorst-Boos J, Carlstrom K, von Schoultz B. Androgen status and sexual life in perimenopausal women. Menopause 1997;4:95-100
56. Plouffe L Jr, Cohen DP. The role of androgens in menopausal hormone replacement therapy. In: Lorrain J, Plouffe Jr L, Ravnikar V, Speroff L, Watts N, eds. Comprehensive Management of Menopause. New York: Springer-Verlag; 1994:297-308
57. Chakravarti S, Collins WP, Newton JR, Oram DH, Studd JW. Endocrine changes and symptomatology after oophorectomy in premenopausal women. Br J Obstet Gynaecol 1977;84:769-775
58. Nathorst-Boos J, von Schoultz B, Carlstrom K. Elective ovarian removal and estrogen replacement therapy-effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol 1993;14:283-293
59. Persky H, Dreisbach L, Miller WR, et al. The relation of plasma androgen levels to sexual behaviors and attitudes of women. Psychosom Med 1982;44:305-319
60. Cawood EH, Bancroft J. Steroid hormones, the menopause, sexuality and well-being of women. Psychol Med 1996;26:925-936
61. Burger HG, Hailes J, Menelaus M, et al. The management of persistent menopausal symptoms with oestradiol-testosterone implants: Clinical, lipid and hormonal results. Maturitas. 1984;6:351-358
62. Sherwin BB, Gelfand MM. Effects of parenteral administration of estrogen and androgen on plasma hormone levels and hot flashes in the surgical menopause. Am J Obstet Gynecol 1984;148:552-557
63. Sherwin BB, Gelfand MM. Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol 1985;151:153-158
64. Sherwin BB, Gelfand MM. Sex steroids and affect in the surgical menopause: A double-blind, cross-over study. Psychoneuroendocrinology 1985;10:325-335
65. Sherwin BB. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord 1988;14:177-187
66. Sherwin BB. The effects of sex steroids on brain mechanisms relating to mood and sexuality. In: Lorrain J, Plouffe Jr L, Ravnikar V, Speroff L, Watts N, eds. Comprehensive Management of Menopause. New York: Springer-Verlag; 1994:327-333
67. Pearce MJ, Hawton K. Psychological and sexual aspects of the menopause and HRT. Baillieres Clin Obstet Gynaecol 1996;10:385-399
68. Uzych L. Anabolic-androgenic steroids and psychiatric-related effects: A review. Can J Psychiatry 1992;37:23-28
69. Kashkin KB, Kleber HD. Hooked on hormones?: An anabolic steroid addiction hypothesis. JAMA 1989;262:3166-3170
70. Tungphaisal S, Chandeying V, Sutthijumroon S, Krisanapan O, Udomratn P. Postmenopausal sexuality in Thai women. Asia Oceania J Obstet Gynaecol 1991;17:143-146
71. Bachmann GA, Leiblum SR, Sandler B, et al. Correlates of sexual desire in postmenopausal women. Maturitas 1985;7:211-216
72. DeFreitas EA, Dudzinski MR, LaRocque JC, Coddington CC. Ovarian vein sampling in rapidly progressing virilization. A case report. J Reprod Med 1991;36:546-548
73. Urman B, Pride SM, Yuen BH. Elevated serum testosterone, hirsutism, and virilism associated with combined androgen-estrogen hormone replacement therapy. Obstet Gynecol 1991;77:595-598
74. Cawood EH, Bancroft J. Steroid hormones, the menopause, sexuality and well-being of women. Psychol Med 1996;26:925-936
75. Kirchengast S, Hartmann B, Gruber D, Huber J. Decreased sexual interest and its relationship to body build in postmenopausal women. Maturitas 1996;23:63-71
76. McCoy NL, Davidson JM. A longitudinal study of the effects of menopause on sexuality. Maturitas 1985;7:203-210
77. Dennerstein L, Dudley EC, Hopper JL, Burger H. Sexuality, hormones and the menopausal transition. Maturitas 1997;26:83-93
78. Dow MG, Hart DM, Forrest CA. Hormonal treatments of sexual unresponsiveness in postmenopausal women: A comparative study. Br J Obstet Gynaecol 1983;90:361-366
79. Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: A prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med 1985;47:339-351
80. Sherwin BB, Gelfand MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 1987;49:397-409
81. Myers LS, Dixen J, Morrissette D, Carmichael M, Davidson JM. Effects of estrogen, androgen, and progestin on sexual psychophysiology and behavior in postmenopausal women. J Clin Endocrinol Metab 1990;70:1124-1131
82. Davis SR, McCloud P, Strauss BJ, Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 1995;21:227-236
83. Kaplan HS, Owett T. The female androgen deficiency syndrome. J Sex Marital Ther 1993;19:3-24
84. Sands R, Studd J. Exogenous androgens in postmenopausal women. Am J Med 1995;98(1A):76S-79S
85. Campbell EC, Udry JR. Implications of hormonal influences on sexual behavior for demographic models of reproduction. Ann N Y Acad Sci 1994;709:117-127
86. Rubinow DR, Schmidt PJ. Androgens, brain, and behavior. Am J Psychiatry 1996;153:974-984
87. Raisz, LG, Wiita B, Artis A, et al. Comparisons of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab 1996;81:37-43
88. Casson PR, Elkind-Hirsch KE, Buster JE, et al. Effect of post-menopausal estrogen replacement on circulating androgens. Obstet Gynecol 1997;90(6):995-998
89. Tazuke S, Shaw K-T, Barrett-Connor E. Exogenous estrogen and endogenous sex hormones. Medicine 1992;72:44-51
90. Simon JA, Klaiber E, Wiita B, et al. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion and endogenous androgen bioavailability in postmenopausal women. Menopause (Submitted for publication)
91. Parker LN, Lifrak ET, Odell WD. A 60,000 molecular weight human pituitary glycopeptide stimulates adrenal androgen secretion. Endocrinology 1983;46:452
92. Albertson BD, Hobson WC, Burnett BS, et al. Dissociation of cortisol adrenal androgen secretion in the hypophy-sectomized ACTH replaced chimpanzee. J Clin Endocrinol Metab 1984;59:13
93. Horton RJ. Testicular steroid transport, metabolism and effects: Androgen and estrogen kinetics. In: De Groot JJ, ed. Principles of Endocrinology and Metabolism. Philadelphia: JP Lippincott Company; 1990:939
94. Carr BR, Parker CR, Madden JD, MacDonald PC, Porter JC. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment. J Clin Endocrinol Metab 1979;49:346-49
95. Madden JD, Milewich L, Parker CR, et al. The effect of oral contraceptives on the serm concentration of dehydroisoandrosterone sulfate. Am J Obstet Gynecol 1978;132:4
96. Wiita B, Artis A, Ackerman D, Longcope C. Binding of a 17-alpha-methyltestosterone in vitro to human sex hormone binding globulin and rat ventral prostate androgen receptors. Ther Drug Monit 1995;17:377-380
97. Hobbs CJ, Jones Re, Plymate SR. The effects of sex hormone binding globulin (SHBG) on testosterone transport into the cerebro-spinal fluid. J Steroid Biochem Mol Biol 1992;42:629-635